annual total liabilities:
$126.86M+$42.83M(+50.97%)Summary
- As of today (September 10, 2025), CPRX annual total liabilities is $126.86 million, with the most recent change of +$42.83 million (+50.97%) on December 31, 2024.
- During the last 3 years, CPRX annual total liabilities has risen by +$95.90 million (+309.78%).
- CPRX annual total liabilities is now at all-time high.
Performance
CPRX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$115.89M+$1.30M(+1.13%)Summary
- As of today (September 10, 2025), CPRX quarterly total liabilities is $115.89 million, with the most recent change of +$1.30 million (+1.13%) on June 30, 2025.
- Over the past year, CPRX quarterly total liabilities has increased by +$18.18 million (+18.61%).
- CPRX quarterly total liabilities is now -8.65% below its all-time high of $126.86 million, reached on December 31, 2024.
Performance
CPRX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CPRX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.0% | +18.6% |
| 3 y3 years | +309.8% | +342.0% |
| 5 y5 years | +412.6% | +473.4% |
CPRX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +309.8% | -8.7% | +342.0% |
| 5 y | 5-year | at high | +457.4% | -8.7% | +535.6% |
| alltime | all time | at high | >+9999.0% | -8.7% | >+9999.0% |
CPRX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $115.89M(+1.1%) |
| Mar 2025 | - | $114.59M(-9.7%) |
| Dec 2024 | $126.86M(+51.0%) | $126.86M(+14.2%) |
| Sep 2024 | - | $111.07M(+13.7%) |
| Jun 2024 | - | $97.70M(+14.6%) |
| Mar 2024 | - | $85.26M(+1.5%) |
| Dec 2023 | $84.03M(+9.8%) | $84.03M(+29.9%) |
| Sep 2023 | - | $64.66M(-5.7%) |
| Jun 2023 | - | $68.60M(-6.7%) |
| Mar 2023 | - | $73.57M(-3.9%) |
| Dec 2022 | $76.55M(+147.3%) | $76.55M(+21.4%) |
| Sep 2022 | - | $63.07M(+140.6%) |
| Jun 2022 | - | $26.22M(-2.0%) |
| Mar 2022 | - | $26.75M(-13.6%) |
| Dec 2021 | $30.96M(+36.0%) | $30.96M(+25.9%) |
| Sep 2021 | - | $24.59M(+21.8%) |
| Jun 2021 | - | $20.19M(+8.7%) |
| Mar 2021 | - | $18.57M(-18.4%) |
| Dec 2020 | $22.76M(-8.0%) | $22.76M(+24.8%) |
| Sep 2020 | - | $18.23M(-9.8%) |
| Jun 2020 | - | $20.21M(+11.0%) |
| Mar 2020 | - | $18.20M(-26.4%) |
| Dec 2019 | $24.75M(+156.0%) | $24.75M(+32.3%) |
| Sep 2019 | - | $18.71M(+25.1%) |
| Jun 2019 | - | $14.95M(+51.0%) |
| Mar 2019 | - | $9.90M(+2.4%) |
| Dec 2018 | $9.67M(+118.5%) | $9.67M(+166.1%) |
| Sep 2018 | - | $3.63M(+12.6%) |
| Jun 2018 | - | $3.23M(+11.9%) |
| Mar 2018 | - | $2.88M(-34.9%) |
| Dec 2017 | $4.42M(+84.5%) | $4.42M(+52.4%) |
| Sep 2017 | - | $2.90M(+44.3%) |
| Jun 2017 | - | $2.01M(-22.7%) |
| Mar 2017 | - | $2.60M(+8.5%) |
| Dec 2016 | $2.40M(-48.2%) | $2.40M(-0.5%) |
| Sep 2016 | - | $2.41M(-7.9%) |
| Jun 2016 | - | $2.62M(-16.4%) |
| Mar 2016 | - | $3.13M(-32.3%) |
| Dec 2015 | $4.63M | $4.63M(+18.2%) |
| Sep 2015 | - | $3.91M(-29.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $5.54M(-41.2%) |
| Mar 2015 | - | $9.43M(+8.8%) |
| Dec 2014 | $8.67M(+117.8%) | $8.67M(-6.0%) |
| Sep 2014 | - | $9.22M(+94.5%) |
| Jun 2014 | - | $4.74M(+3.3%) |
| Mar 2014 | - | $4.59M(+15.4%) |
| Dec 2013 | $3.98M(+83.6%) | $3.98M(-39.5%) |
| Sep 2013 | - | $6.58M(+143.5%) |
| Jun 2013 | - | $2.70M(+74.4%) |
| Mar 2013 | - | $1.55M(-28.5%) |
| Dec 2012 | $2.17M(-12.9%) | $2.17M(-20.0%) |
| Sep 2012 | - | $2.71M(+109.6%) |
| Jun 2012 | - | $1.29M(-43.1%) |
| Mar 2012 | - | $2.27M(-8.7%) |
| Dec 2011 | $2.49M(+693.3%) | $2.49M(+488.7%) |
| Sep 2011 | - | $422.70K(-35.6%) |
| Jun 2011 | - | $656.10K(-24.9%) |
| Mar 2011 | - | $873.10K(+178.3%) |
| Dec 2010 | $313.70K(-10.0%) | $313.70K(-24.4%) |
| Sep 2010 | - | $414.80K(-16.8%) |
| Jun 2010 | - | $498.60K(+30.7%) |
| Mar 2010 | - | $381.40K(+9.4%) |
| Dec 2009 | $348.50K(-76.3%) | $348.50K(+10.5%) |
| Sep 2009 | - | $315.30K(-37.9%) |
| Jun 2009 | - | $507.40K(-67.8%) |
| Mar 2009 | - | $1.58M(+7.0%) |
| Dec 2008 | $1.47M(+312.3%) | $1.47M(+16.3%) |
| Sep 2008 | - | $1.27M(+60.5%) |
| Jun 2008 | - | $788.90K(+61.3%) |
| Mar 2008 | - | $489.10K(+36.9%) |
| Dec 2007 | $357.20K(-53.8%) | $357.20K(-11.8%) |
| Sep 2007 | - | $405.10K(-3.2%) |
| Jun 2007 | - | $418.50K(-20.2%) |
| Mar 2007 | - | $524.30K(-32.2%) |
| Dec 2006 | $772.80K(+125.3%) | $772.80K(+12.6%) |
| Sep 2006 | - | $686.50K(+58.0%) |
| Jun 2006 | - | $434.40K(+26.6%) |
| Dec 2005 | $343.00K(+405.9%) | $343.00K(+405.9%) |
| Dec 2004 | $67.80K(+26.3%) | $67.80K |
| Dec 2003 | $53.70K(-19.5%) | - |
| Dec 2002 | $66.70K | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual total liabilities year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual total liabilities?
The current annual total liabilities of CPRX is $126.86M
What is the all time high annual total liabilities for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual total liabilities is $126.86M
What is Catalyst Pharmaceuticals, Inc. annual total liabilities year-on-year change?
Over the past year, CPRX annual total liabilities has changed by +$42.83M (+50.97%)
What is Catalyst Pharmaceuticals, Inc. quarterly total liabilities?
The current quarterly total liabilities of CPRX is $115.89M
What is the all time high quarterly total liabilities for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly total liabilities is $126.86M
What is Catalyst Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
Over the past year, CPRX quarterly total liabilities has changed by +$18.18M (+18.61%)